Mariama Akodad
- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Aortic Disease and Treatment Approaches
- Coronary Interventions and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Mechanical Circulatory Support Devices
- Congenital Heart Disease Studies
- Heart Failure Treatment and Management
- Cardiac and Coronary Surgery Techniques
- Viral Infections and Immunology Research
- Inflammasome and immune disorders
- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Advanced MRI Techniques and Applications
- Aortic aneurysm repair treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrest and Resuscitation
- Cardiac tumors and thrombi
- Cardiac Arrhythmias and Treatments
- Pericarditis and Cardiac Tamponade
- Advanced X-ray and CT Imaging
Université Paris Cité
2025
Assistance Publique – Hôpitaux de Paris
2025
Hôpital américain de paris
2025
Inserm
2016-2025
Institut Cardiovasculaire Paris Sud
2017-2025
Hôpital Privé Jacques Cartier
2019-2025
Siemens (France)
2025
Générale de Santé
2017-2025
St. Paul's Hospital
2021-2024
Université de Montpellier
2015-2024
Inflammation is a key factor of myocardial damage in reperfused ST-segment-elevation infarction. We hypothesized that colchicine, potent anti-inflammatory agent, may reduce infarct size (IS) and left ventricular (LV) remodeling at the acute phase infarction.In this double-blind multicenter trial, we randomly assigned patients admitted for first episode infarction referred primary percutaneous coronary intervention to receive oral colchicine (2-mg loading dose followed by 0.5 mg twice day) or...
With growing adoption of coronary computed tomographic angiography (CTA), there is increasing evidence for and interest in the prognostic importance atherosclerotic plaque volume. Manual tools segmentation are cumbersome, their routine implementation clinical practice limited. The aim this study was to develop nomographic quantitative values from a large consecutive multicenter cohort using CTA. Quantitative assessment total subtype volumes performed patients undergoing clinically indicated...
Coronary obstruction and access are concerns in patients undergoing redo transcatheter aortic valve implantation (TAVI).
Abstract Background and Aims Transcatheter pulmonary valve implantation (TPVI) is indicated to treat right-ventricular outflow tract (RVOT) dysfunction related congenital heart disease (CHD). Outcomes of TPVI with the SAPIEN 3 that are insufficiently documented were investigated in EUROPULMS3 registry 3-TPVI. Methods Patient-related, procedural, follow-up outcome data retrospectively assessed this observational cohort from 35 centres 15 countries. Results Data for 840 consecutive patients...
Transcatheter mitral valve replacement (TMVR) using dedicated devices is an alternative therapy for high-risk patients with symptomatic regurgitation (MR).
Journal Article Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial Get access Fabien Huet, Huet Department of Cardiology, Vannes Regional Hospital, 20 Bd Général Maurice Guillaudot, 56000 Vannes, FranceDepartment Montpellier University 191 Av. du Doyen Gaston Giraud, 34295 Cedex 5, FrancePhyMedExp, Université de Montpellier, INSERM, CNRS, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Denis...